Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:person
|
| gptkbp:awardReceived |
gptkb:Austrian_Cross_of_Honour_for_Science_and_Art
|
| gptkbp:dateOfBirth |
1956-01-10
|
| gptkbp:doctoralAdvisor |
Oskar Jeger
|
| gptkbp:education |
gptkb:ETH_Zurich
gptkb:University_of_Innsbruck |
| gptkbp:employer |
gptkb:Gilead_Sciences
|
| gptkbp:fieldOfWork |
medicinal chemistry
pharmaceutical industry |
| https://www.w3.org/2000/01/rdf-schema#label |
Norbert Bischofberger
|
| gptkbp:knownFor |
co-inventor of oseltamivir (Tamiflu)
|
| gptkbp:nationality |
gptkb:Austrian
|
| gptkbp:occupation |
biologist
chemist |
| gptkbp:placeOfBirth |
gptkb:Hard,_Austria
|
| gptkbp:positionHeld |
Chief Scientific Officer at Gilead Sciences
|
| gptkbp:bfsParent |
gptkb:Gilead_Sciences,_Inc.
gptkb:oseltamivir |
| gptkbp:bfsLayer |
6
|